...
机译:患者转型至透析后末期肾病血清白蛋白与终末期肾病的关联
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Los Angeles David Geffen Sch Med Harbor UCLA Med Ctr Los Angeles Biomed Res Inst Div;
Univ Tennessee Hlth Sci Ctr Div Nephrol Memphis TN USA;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
Univ Calif Irvine Harold Simmons Ctr Kidney Dis Res &
Epidemiol Dept Med Div Nephrol &
Hypertens;
机译:患者转型至透析后末期肾病血清白蛋白与终末期肾病的关联
机译:末期前阶段肾病血红蛋白变异性预测转换为透析的患者的终末期肾病死亡率
机译:前阶段肾脏疾病前参阅入场的收缩压变异性和入射透析患者的末期肾病死亡率
机译:慢性肾病和透析患者心肺手术风险的负担(甘蓝综合征4型)
机译:正在进行维持性血液透析或连续性非循环性腹膜透析治疗(疾病,饮食疗法)的肾病患者血清脂水平的影响因素。
机译:终末期肾病血清碱性磷酸酶对晚期慢性肾病患者向透析治疗的终末期肾病死亡率的预后意义
机译:前阶段肾病患者参观参观的收缩压变异性和入射透析患者的末期肾病死亡率